Sevabertinib Approval Narrows HER2-Mutated NSCLC Use
FDA cleared Dexcom Stelo for over-the-counter use in people aged 2 years and older without insulin use, expanding access while leaving clinical outcomes uncertain.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.